Learn / XERS
NASDAQ: XERS
Xeris Biopharma Holdings (XERS) stock, explained like you're 5
Xeris Biopharma Holdings trades on the Nasdaq under the ticker XERS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.
- Ticker
- XERS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.9 billion dollars
Is Xeris Biopharma Holdings a small, medium or large cap company?
No. Xeris Biopharma Holdings is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.9 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Xeris Biopharma Holdings makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves XERS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- In one Cushing's case, cortisol normalized after treatment; insulin and blood pressure drugs were discontinued. (Stock Titan)
- How Conference Data Presentations At Xeris Biopharma Holdings (XERS) Have Changed Its Investment Story (Simply Wall Street)
- XERS Nov 2026 10.000 call (XERS261120C00010000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Xeris Biopharma CLO Beth Hecht sells $156,792 in XERS shares (Investing.com)
- Xeris files KEVEYIS suits. Barclays lifts target for Xeris Biopharma Holdings stock (ad-hoc-news.de)
Follow XERS in your daily brief
Each trading day at 5 PM ET we post what happened to Xeris Biopharma Holdings and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow XERS
Questions about Xeris Biopharma Holdings stock
What does Xeris Biopharma Holdings do?
Xeris Biopharma Holdings trades on the Nasdaq under the ticker XERS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.
What is the ticker symbol for Xeris Biopharma Holdings?
Xeris Biopharma Holdings trades under the ticker XERS on the Nasdaq.
What is Xeris Biopharma Holdings's market cap?
Xeris Biopharma Holdings is a small cap stock with a market cap of about 1.9 billion dollars.
How does Xeris Biopharma Holdings make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves XERS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow XERS stock every day?
Add XERS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.